Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction
NCT ID: NCT01594086
Last Updated: 2013-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2012-05-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Catechin High Contain Greentea Extract on Improvement of Cognitive Function
NCT03826017
Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex
NCT01615289
Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.
NCT01923597
Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions
NCT01315977
Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients
NCT02731495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Green tea contains catechins and theanine as main ingredients. These components are reported to have anti-atherogenic action and effect on improving cognitive dysfunction. However, clinical evidence for homocysteine metabolism and cognitive dysfunction has not been clarified. Therefore, in this study, the investigators attempted to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
green tea powder
Natural green tea powder
green tea powder
Consuming 2 g/day of green tea powder in three times divided for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
green tea powder
Consuming 2 g/day of green tea powder in three times divided for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Possible to consume green tea powder
* Possessing cognitive dysfunction; MMSE score less than 30
* Possible not to take any supplement possessing anti-oxidizing effect; i.e., vitamin A, C, E, β-carotene
Exclusion Criteria
* Possessing severe cardiac, respiratory, renal, or hepatic dysfunction
* Possessing severe anemia
* Diagnosed as inadequate to participate in the study by doctor
50 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Shizuoka
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yamada, Hiroshi
Role: STUDY_CHAIR
University of Shizuoka
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
White Cross Nursing Home
Higashimurayama, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24220501
Identifier Type: OTHER
Identifier Source: secondary_id
CT201201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.